Distribution companies burden additional KRW 186.9 billion for real-time reporting system

It was observed pharmaceutical distribution companies will need to pay additional expenses more than KRW 180 billion to make reports for drug serial numbers in real-time, which is scheduled to be enforced on July.

The Korea Pharmaceutical Distribution Association revealed the research result for device and personnel expenses for the enforcement on 1,991 companies after conducting a sample surv...